Chemotherapy: What progress in the last 5 years?

[71] Hortobagyi GN, 1999, J CLIN ONCOL, V17, P25

[72] HORTOBAGYI GN, 2000, DIS BREAST, P645

[73] HORTOBAGYI GN, 2002, P AN M AM SOC CLIN, V21, P192

[74] HURLEY J, 2000, P AN M AM SOC CLIN, V19, pA127

[75] Hurley JE, 2001, BREAST CANCER RES TR, V69, P300

[76] Hutcheon AW, 2003, BREAST CANCER RES TR, V82, pS9

[77] Jackisch C, 2003, BREAST CANCER RES TR, V82, pS51

[78] Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2+ metastatic breast cancer [J]. ONCOLOGIST, 2002, 7 (05) : 410 - 417

[79] RANDOMIZED COMPARISON OF VINORELBINE AND MELPHALAN IN ANTHRACYCLINE-REFRACTORY ADVANCED BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) : 2567 - 2574

[80] JONES S, 2004, BREAST CANC RES TREA, V82, P59

[71] Hortobagyi GN, 1999, J CLIN ONCOL, V17, P25

[72] HORTOBAGYI GN, 2000, DIS BREAST, P645

[73] HORTOBAGYI GN, 2002, P AN M AM SOC CLIN, V21, P192

[74] HURLEY J, 2000, P AN M AM SOC CLIN, V19, pA127

[75] Hurley JE, 2001, BREAST CANCER RES TR, V69, P300

[76] Hutcheon AW, 2003, BREAST CANCER RES TR, V82, pS9

[77] Jackisch C, 2003, BREAST CANCER RES TR, V82, pS51

[78] Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2+ metastatic breast cancer [J]. ONCOLOGIST, 2002, 7 (05) : 410 - 417

[79] RANDOMIZED COMPARISON OF VINORELBINE AND MELPHALAN IN ANTHRACYCLINE-REFRACTORY ADVANCED BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) : 2567 - 2574

[80] JONES S, 2004, BREAST CANC RES TREA, V82, P59